NYSE:MMS - MAXIMUS Stock Price, Forecast & News

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS declared a quarterly dividend on Wednesday, January 8th. Shareholders of record on Friday, February 14th will be paid a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Thursday, February 13th. View MAXIMUS's Dividend History.

MAXIMUS announced that its board has authorized a stock buyback plan on Monday, June 25th 2018, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 4.9% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) announced its quarterly earnings results on Tuesday, November, 19th. The health services provider reported $0.93 EPS for the quarter, missing the Zacks' consensus estimate of $0.94 by $0.01. The health services provider had revenue of $754.97 million for the quarter, compared to analysts' expectations of $756.40 million. MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. MAXIMUS's revenue was up 35.2% compared to the same quarter last year. During the same period last year, the company earned $0.71 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for MAXIMUS.

MAXIMUS will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

MAXIMUS issued an update on its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $$3.95-4.15 for the period, compared to the Thomson Reuters consensus estimate of $$4.07. The company issued revenue guidance of $$3.15-3.3 billion, compared to the consensus revenue estimate of $$3.17 billion.

2 brokers have issued 12-month price objectives for MAXIMUS's shares. Their forecasts range from $77.00 to $81.00. On average, they expect MAXIMUS's share price to reach $79.00 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Media stories about MMS stock have trended somewhat positive on Tuesday, according to InfoTrie. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. MAXIMUS earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave press coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for MAXIMUS.

MAXIMUS saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,670,000 shares, an increase of 6.4% from the December 15th total of 1,570,000 shares. Based on an average trading volume of 393,600 shares, the short-interest ratio is currently 4.2 days. Approximately 2.6% of the company's stock are short sold. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Fiserv (FISV), Automatic Data Processing (ADP), Global Payments (GPN), Worldpay (WP), Paychex (PAYX), FleetCor Technologies (FLT), Total System Services (TSS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), WEX (WEX) and Euronet Worldwide (EEFT).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Altria Group (MO), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Wells Fargo & Co (WFC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Dominion Energy (D) and New Oriental Education & Tech Grp (EDU).

MAXIMUS's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.73%), State of Michigan Retirement System (0.72%), California Public Employees Retirement System (0.34%), New York State Teachers Retirement System (0.16%), West Coast Financial LLC (0.16%) and Reinhart Partners Inc. (0.15%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Falcon Point Capital LLC, Strs Ohio, Riverbridge Partners LLC, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, Arizona State Retirement System, Dupont Capital Management Corp and State of Alaska Department of Revenue. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

MMS stock was acquired by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, Reinhart Partners Inc., Assenagon Asset Management S.A., California Public Employees Retirement System, Zeke Capital Advisors LLC, Private Trust Co. NA, Virginia Retirement Systems ET AL and HGK Asset Management Inc.. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $73.48.

MAXIMUS has a market capitalization of $4.70 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]